Mailroom Scanners

PRODUCTS

  • Enables secure real-time document review, co-authoring, and redaction in order to shorten the document review process by up to 65%.

  • KRYTAR End Launch Terminations feature a unique, integrated termination, eliminating the additional cost and complexity of typical coaxial terminations.

  • An excellent alternative to traveling wave tube amplifiers, Qorvo’s Spatium QPB1024 is a solid state, spatialcombining amplifier with an operating range of 8.0 – 11.0 GHz while achieving greater than 57 dBm (500 Watts) of instantaneous saturated power. 

  • Rapidly advance your allogeneic development with a hypoimmunogenic iPSC platform that has pre-built TARGATT™ large knock-in technology.

  • There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough understanding of sections 505(b)(1) and 505(b)(2) of the Federal Food, Drug, and Cosmetics (FD&C) Act.

WHITE PAPERS AND CASE STUDIES

NEWS

  • Akoustis Receives Wi-Fi 7 Design Win From Tier-1 US-Based Carrier
    2/12/2024

    Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that two of its patented XBAW® filters are being integrated into a Wi-Fi 7 router platform with a leading US-based carrier, catering to more than 32 million residential customers.

  • ProBioGen Enters Agreement With Polpharma Biologics To Provide High-Performance Cell Line Development Services
    5/7/2025

    ProBioGen announced today an agreement with Polpharma Biologics, an international biotech company dedicated to the development and manufacture of biosimilars. Under this agreement ProBioGen will conduct high-performance cell line development services for Polpharma's biosimilar candidate, supporting their expanding pipeline.

  • AbTherx And Dragonfly Therapeutics Expand Antibody Discovery Partnership
    9/23/2025

    AbTherx, a biotechnology company pioneering technologies that accelerate antibody discovery, today announced an expansion of its ongoing partnership with Dragonfly Therapeutics (Dragonfly) following a successful multi-target pilot study comparing transgenic platforms.

  • Verizon To Acquire Frontier
    9/5/2024

    Verizon Communications Inc. (NYSE, NASDAQ: VZ) and Frontier Communications Parent, Inc. (NASDAQ: FYBR) today announced they have entered into a definitive agreement for Verizon to acquire Frontier in an all-cash transaction valued at $20 billion.

  • API Releases Bulletin Demonstrating The Suitability Of Portland Cement For CCUS Projects
    11/6/2025

    The American Petroleum Institute (API) today announced the publication of API Bulletin 5100, Ordinary Portland Cement as a Barrier for Carbon Capture, Utilization, and Storage (CCUS) Applications.